Indirect Comparison Showed Survival Benefit from Adjuvant Chemoradiotherapy in Completely Resected Gastric Cancer with D2 Lymphadenectomy
Background. Little data on directly comparing chemoradiotherapy with observation has yet been published in the setting of adjuvant therapy for resected gastric cancer who underwent D2 lymphadenectomy. The present indirect comparison aims to provide more evidence on comparing the two approaches. Meth...
Saved in:
Main Authors: | Qiong Yang, Ying Wei, Yan-Xian Chen, Si-Wei Zhou, Zhi-Min Jiang, De-Rong Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2013/634929 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Post-chemoradiotherapy adjuvant chemotherapy of rectal cancer
by: E. V. Ledin, et al.
Published: (2018-08-01) -
Chylous Fistula following Axillary Lymphadenectomy: Benefit of Octreotide Treatment
by: Elena González-Sánchez-Migallón, et al.
Published: (2016-01-01) -
Evaluating survival outcomes and treatment recommendations in resectable gastric cancer
by: Saad Sabbagh, et al.
Published: (2025-01-01) -
Monitoring of Circulating Tumor DNA and Indication of De-Escalation Adjuvant Targeted Therapy for EGFR-Mutated NSCLC After Complete Resection
by: Song Dong, PhD, et al.
Published: (2025-01-01) -
The Extent of Lymphadenectomy at the Time of Radical Cystectomy for Bladder Cancer and its Impact on Prognosis and Survival
by: David Y. Josephson, et al.
Published: (2005-01-01)